UPDATE 1-Cancer center CEO leaves Merck board after disclosure scandal
October 02, 2018 at 17:20 PM EDT
The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.
